LONG-ACTING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISM MITIGATES INFLAMMATION AND FIBROSIS IN MODELS OF NASH AND BILIARY FIBROSIS

被引：0
|
作者：
Wang, X. -Y. [1 ]
Weng, S. -Y. [1 ]
Kim, Y. O. [1 ]
Klein, T. [2 ]
Schuppan, D. [1 ,3 ]
机构：
[1] Inst Translat Immunol, Mainz, Germany
[2] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[3] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)60791-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P629
引用
收藏
页码：S278 / S278
页数：1
相关论文
共 50 条
  • [41] Glucagon-Like Peptide-1 Receptor Agonists and Osteoarthritis
    Felson, David T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (17): : 1643 - 1644
  • [42] SIGNAL TRANSDUCTION OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR
    LU, M
    WHEELER, MB
    DILLON, J
    LENG, XH
    CHEN, C
    BOYD, AE
    DIABETES, 1993, 42 : A76 - A76
  • [43] Physiology and pharmacology of glucagon-like peptide-1 receptor
    Kurkin, D. V.
    Bakulin, D. A.
    Morkovin, E. I.
    Petrov, V. I.
    Strygin, A. V.
    Koryanova, K. N.
    Gorbunova, Yu. V.
    Kolosov, Yu. A.
    Ivanova, O. V.
    Pavlova, E. V.
    Dzhavahyan, M. A.
    Zaborovsky, A. V.
    Saparova, V. B.
    Makarenko, I. E.
    Drai, R. I.
    Chumachenko, A. N.
    PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYA, 2023, 11 (04): : 347 - 380
  • [44] Understanding signaling at the glucagon-like peptide-1 receptor
    Sexton, Patrick M.
    Pabreja, Kavita
    Koole, Cassandra
    Savage, Emilia E.
    Furness, Sebastian G.
    Christopoulos, Arthur
    Wootten, Denise
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 89 - 89
  • [45] Pitfalls in Glucagon-Like Peptide-1 Receptor Imaging
    Antwi, K.
    Hepprich, M.
    Reubi, J. C.
    Christ, E.
    Wild, D.
    NEUROENDOCRINOLOGY, 2020, 110 : 248 - 248
  • [46] Obesity and Glucagon-Like Peptide-1 Receptor Agonists
    Celletti, Francesca
    Branca, Francesco
    Farrar, Jeremy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (07): : 561 - 562
  • [47] Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists
    Khan, Sadiya S.
    Ndumele, Chiadi E.
    Kazi, Dhruv S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (02): : 113 - 114
  • [48] Glucagon-Like Peptide-1 Receptor: A Novel Receptor in Platelets
    Kahal, Hassan
    Aburima, Ahmed
    Spurgeon, Benjamin
    Wraith, Katie S.
    Ghavideldarestani, Maryam
    Rizvi, Faran
    Sturmey, Roger G.
    Kilpatrick, Eric S.
    Atkin, Stephen L.
    Naseem, Khalid M.
    DIABETES, 2015, 64 : A528 - A528
  • [49] The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis
    Li, Ya-Kun
    Ma, Dong-Xia
    Wang, Zhi-Min
    Hu, Xiao-Fan
    Li, Shang-Lin
    Tian, Hong-Zhe
    Wang, Meng-Jun
    Shu, Yan-Wen
    Yang, Jun
    PHARMACOLOGICAL RESEARCH, 2018, 131 : 102 - 111
  • [50] Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism
    Lei, Saifei
    Clydesdale, Lachlan
    Dai, Antao
    Cai, Xiaoqing
    Feng, Yang
    Yang, Dehua
    Liang, Yi-Lynn
    Koole, Cassandra
    Zhao, Peishen
    Coudrat, Thomas
    Christopoulos, Arthur
    Wang, Ming-Wei
    Wootten, Denise
    Sexton, Patrick M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (24) : 9370 - 9387
12345